410
Views
19
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Evaluation of Lactate Dehydrogenase and Alkaline Phosphatase as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram

, , , , , , , , , , , & ORCID Icon show all
Pages 69-79 | Received 22 Nov 2022, Accepted 05 Jan 2023, Published online: 14 Jan 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Ruyu Han, Leijuan Gan, Mengran Lang, Guangtao Li, Lu Chen, Xindi Tian, Kangwei Zhu, Liyu Sun & Tianqiang Song. (2024) A Retrospective Study on Predicting Recurrence of Intermediate-Stage Hepatocellular Carcinoma After Radical Therapy. Journal of Hepatocellular Carcinoma 11, pages 51-64.
Read now
Zhikai Zheng, Jiongliang Wang, Tianqing Wu, Minrui He, Juncheng Wang, Yangxun Pan, Jinbin Chen, Dandan Hu, Li Xu, Yaojun Zhang, Minshan Chen & Zhongguo Zhou. (2023) Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy. Journal of Hepatocellular Carcinoma 10, pages 2117-2132.
Read now
Hai-Feng Liu, Yang Lu, Qing Wang, Yu-Jie Lu & Wei Xing. (2023) Machine Learning-Based CEMRI Radiomics Integrating LI-RADS Features Achieves Optimal Evaluation of Hepatocellular Carcinoma Differentiation. Journal of Hepatocellular Carcinoma 10, pages 2103-2115.
Read now
Jiaojiao Gong, Renjie Yu, Xiaoxia Hu, Huating Luo, Qingzhu Gao, Yadi Li, Guili Tan, Haiying Luo & Bo Qin. (2023) Development and Validation of a Novel Prognosis Model Based on a Panel of Three Immunogenic Cell Death-Related Genes for Non-Cirrhotic Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 10, pages 1609-1628.
Read now
Xuqi Sun, Yangyang Wang, Hongbin Ge, Cao Chen, Xu Han, Ke Sun, Meng Wang, Xiaobao Wei, Mao Ye, Qi Zhang & Tingbo Liang. (2023) Development and Validation of Novel Models Including Tumor Micronecrosis for Predicting the Postoperative Survival of Patients with Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 10, pages 1181-1194.
Read now
Xiangze Wang, Minghui Zhao, Chensheng Zhang, Haobo Chen, Xingyu Liu, Yang An, Lu Zhang & Xiangqian Guo. (2023) Establishment and Clinical Application of the Nomogram Related to Risk or Prognosis of Hepatocellular Carcinoma: A Review. Journal of Hepatocellular Carcinoma 10, pages 1389-1398.
Read now

Articles from other publishers (13)

Parisa Shamshiripour, Mehrana Rahnama, Mehdi Nikoobakht, Fahimeh Hajiahmadi, Ali-reza Moradi & Davoud Ahmadvand. (2024) A dynamic study of VEGF-A siDOX-EVs trafficking through the in-vitro insert co-culture blood-brain barrier model by digital holographic microscopy. Frontiers in Oncology 14.
Crossref
Xueting Li, Xiaorong Zhong, Hongyu Xu, Jun Wang, Xianguo Liu, Yang Wang, Liang He, Jiayu Ma, Guanghua Li & Lei Liu. (2024) Survival analysis of palliative radiotherapy in patients with HER-2+ metastatic breast cancer. Frontiers in Endocrinology 14.
Crossref
Wan-Jing Feng, Xiao-Ying Zhao, Yi-Fu He, Ming-Zhu Huang, Zhi-Yu Chen, Yu-Sheng Wang, Xiao-Dong Zhu & Wei-Jian Guo. (2024) Multivariate prognostic index and triplet regimen efficacy predictive index in locally advanced and metastatic gastric cancer: pooled analysis from three clinical trials using individual patient data. Therapeutic Advances in Medical Oncology 16.
Crossref
Chengyuan Dong, Yadong Guo, Ping Wang, Shiqi Yin & Xin Ge. (2023) Comprehensive analysis of disulfidptosis-related lncRNA features for prognosis and immune landscape prediction in colorectal cancer. Frontiers in Oncology 13.
Crossref
Wei-Qiao Zhang, Qiao Zhang, Li Tan, Zhi-Feng Guan, Feng Tian, Hong-Tao Tang, Kun He & Wei-Qiang Chen. (2023) Postoperative adjuvant immunotherapy for high-risk hepatocellular carcinoma patients. Frontiers in Oncology 13.
Crossref
Yikai Wang, Muqi Wang, Chenrui Liu, Miao Hao, Wenjun Wang, Yaping Li, Juanjuan Shi, Xin Zhang & Shuangsuo Dang. (2023) Hepatoprotective effects of aspirin on diethylnitrosamine-induced hepatocellular carcinoma in rats by reducing inflammation levels and PD-L1 expression. Scientific Reports 13:1.
Crossref
Yuxin Liang, Ruoyi Yang, Jin Shang, Deyuan Zhong, Qinyan Yang, Yuhao Su, Ying Shi & Xiaolun Huang. (2023) Lung immune prognostic index‑based nomogram for recurrence of hepatocellular carcinoma after postoperative adjuvant TACE. Journal of Cancer Research and Clinical Oncology 149:18, pages 16461-16471.
Crossref
Zhenyong Xiao, Jinwei Li, Cong Liang, Yamei Liu, Yuxiu Zhang, Yuxia Zhang, Quan Liu & Xianlei Yan. (2023) Identification of M5c regulator-medicated methylation modification patterns for prognosis and immune microenvironment in glioma. Aging 15:21, pages 12275-12295.
Crossref
Tuoyu Ju, Jianjun Dong, Bowei Wang, Kaige Qu, Can Cheng, Xiuxia He, Yanling Tian, M. James C. CrabbeZuobin Wang & Yujuan Chen. (2023) Cancer Development in Hepatocytes by Long-Term Induction of Hypoxic Hepatocellular Carcinoma Cell (HCC)-Derived Exosomes In Vivo and In Vitro . Molecular Pharmaceutics 20:11, pages 5579-5592.
Crossref
Yi Jiang, Lu Guo, Lei Han, Han Li, Changlun Li, Lianbin Wen, Yanqiong Song, Zhaoyang Wang, Pan Wang, Qulian Guo, Wenxi Zhao, Mengxiang Liu, Jiali Chen, Zhenying Wu, Yushan Yan, Ke Xu, Tao Gu, Xue Wu, Kun He, Ke Su & Yunwei Han. (2023) Thymidine kinase 1 appears to be a marker for the prognosis of hepatocellular carcinoma based on a large-scale, multicenter study. Journal of Cancer Research and Clinical Oncology 149:15, pages 14271-14282.
Crossref
Ke Su, Fei Wang, Xueting Li, Hao Chi, Jianwen Zhang, Kun He, Zhaoyang Wang, Lianbin Wen, Yanqiong Song, Jiali Chen, Zhenying Wu, Yi Jiang, Han Li, Tao Gu, Chenjie Wang, Yaqi Li, Mengxiang Liu, Qulian Guo, Ke Xu, Lu Guo & Yunwei Han. (2023) Effect of external beam radiation therapy versus transcatheter arterial chemoembolization for non-diffuse hepatocellular carcinoma (≥ 5 cm): a multicenter experience over a ten-year period. Frontiers in Immunology 14.
Crossref
Hao Zeng, Ke Su, Xiaojing Chen, Xueting Li, Lianbin Wen, Yanqiong Song, Lan Chen, Han Li, Lu Guo & Yunwei Han. (2023) A propensity score matching study on survival benefits of radiotherapy in patients with inoperable hepatocellular carcinoma. Scientific Reports 13:1.
Crossref
Manon Falette-Puisieux, Jean-Charles Nault, Mohamed Bouattour, Marie Lequoy, Giuliana Amaddeo, Thomas Decaens, Frederic Di Fiore, Sylvain Manfredi, Philippe Merle, Aurore Baron, Christophe Locher, Anna Pellat & Romain Coriat. (2023) Beyond atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma: overall efficacy and safety of tyrosine kinase inhibitors in a real-world setting. Therapeutic Advances in Medical Oncology 15.
Crossref